Capsule
Latest Warner-Lambert Company Patents:
- Methods of treating neurofibromatosis type 1 with N-((R))-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
- COMPOSITIONS OF ESSENTIALLY PURE FORM IV OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO-PHENYLAMINO)-BENZAMIDE AND USES THEREOF
- Methods of treating neurofibromatosis with N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
- METHODS OF TREATING NEUROFIBROMATOSIS WITH N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)-BENZAMIDE
- Compositions of essentially pure form IV of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
Description
FIG. 1 is a perspective view of the capsule;
FIG. 2 is a top end view of the capsule;
FIG. 3 is a bottom end view of the capsule;
FIG. 4 is a side view of the capsule; and,
FIG. 5 is a rotated side view of the capsule.
Referenced Cited
U.S. Patent Documents
| D237199 | October 1975 | Sunter |
| 4040536 | August 9, 1977 | Schwarz |
Patent History
Patent number: D430932
Type: Grant
Filed: Dec 22, 1998
Date of Patent: Sep 12, 2000
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventors: Phillip Vickery (Greenwood, SC), Walter V. Corley (Laurens, SC), Bruce DeMars (Bloomington, IN), James Poston (Greenwood, SC)
Primary Examiner: Antoine Duval Davis
Attorney: Charles W. Almer
Application Number: 0/98,135
Type: Grant
Filed: Dec 22, 1998
Date of Patent: Sep 12, 2000
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventors: Phillip Vickery (Greenwood, SC), Walter V. Corley (Laurens, SC), Bruce DeMars (Bloomington, IN), James Poston (Greenwood, SC)
Primary Examiner: Antoine Duval Davis
Attorney: Charles W. Almer
Application Number: 0/98,135
Classifications
